SEP 22·SEC EDGARLow
WITTMAN VANESSA AMES sold $806K of OSCR
WITTMAN VANESSA AMES sold 25,000 shares of Oscar Health, Inc. (OSCR) at $32.24 ($0.81M total) on 2026-09-18 under a Rule 10b5-1 trading plan.
StockNYSE · US · USDHealthcare · Healthcare Plans
$OSCR
Oscar Health, Inc.
AlphAI earnings readsecond quarter 2026 · AUG 6Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 OutlookVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $OSCRvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $OSCR in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $806K 1 txs
WITTMAN VANESSA AMES1× · $806K
10b5-1 share of filings100%
Top stories · $OSCRMore →
SEP 22·tradingview.com
U.S. to remove hundreds of thousands of Obamacare enrollees
The Trump administration plans to remove 750,000 ACA enrollees due to alleged fraud, saving $2.2B. Affected individuals include those unaware of enrollments, high earners, and those with employer-provided healthcare. Leading ACA marketplace operators traded lower on the news.
SEP 17·investing.com
Piper Sandler raises Oscar Health stock price target on ACA growth
Piper Sandler raised its price target for Oscar Health (OSCR) to $48, citing ACA growth and a 12x multiple on 2030 earnings. The stock has surged 139% in six months, with analysts predicting profitability this year. Oscar Health reported strong Q2 2026 results, exceeding earnings and revenue expectations, and raised its 2026 guidance.
OSCR sentiment & insider activity
Recent OSCR coverage spans earnings, insider activity and regulation.
In the last 30 days, OSCR insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($806K). The most active reporter was WITTMAN VANESSA AMES with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving OSCR
The insider sale may signal limited confidence from a director, but the amount is modest relative to holdings.
Oscar Health could see a hit to its top line.
Analyst upgrade and strong earnings suggest upside potential.
Higher target may buoy the stock.
Guidance uplift suggests higher revenue growth and profitability, likely supporting the stock price.
AlphAI scores every news story that mentions OSCR with an AI model for sentiment and relevance, and aggregates insider trades from Oscar Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $OSCR
Score
WITTMAN VANESSA AMES sold $806K of OSCR
WITTMAN VANESSA AMES sold 25,000 shares of Oscar Health, Inc. (OSCR) at $32.24 ($0.81M total) on 2026-09-18 under a Rule 10b5-1 trading plan.
1 min read
U.S. to remove hundreds of thousands of Obamacare enrollees
The Trump administration plans to remove 750,000 ACA enrollees due to alleged fraud, saving $2.2B. Affected individuals include those unaware of enrollments, high earners, and those with employer-provided healthcare. Leading ACA marketplace operators traded lower on the news.
2 min readPiper Sandler raises Oscar Health stock price target on ACA growth
Piper Sandler raised its price target for Oscar Health (OSCR) to $48, citing ACA growth and a 12x multiple on 2030 earnings. The stock has surged 139% in six months, with analysts predicting profitability this year. Oscar Health reported strong Q2 2026 results, exceeding earnings and revenue expectations, and raised its 2026 guidance.
2 min readAnalyst recommendations: Copart, SentinelOne, Fortinet, Palo Alto
Analysts adjusted ratings and price targets for several companies. HSBC downgraded Copart to hold, lowering its target to $36. Bernstein downgraded Palo Alto Networks and SentinelOne but raised their targets. Fortinet's target was raised by Bernstein, while Pegasystems' was cut by JP Morgan. Other companies affected include J&J, Generac, Mks, Oscar Health, and Wingstop.
2 min readOSCR: Raised 2026–2029 guidance, targeting 20%+ revenue CAGR, 5–7% margins, and $4+ EPS, driven by ACA and AI
Oscar Health (OSCR) raised its 2026–2029 guidance, targeting 20%+ revenue CAGR, 5–7% margins, and $4+ EPS, driven by ACA expansion and AI. The company aims to lead the individual health market through AI efficiency and product innovation, with the Lucie Health Marketplace as a long-term opportunity, though not critical to targets.
1 min readOSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises
Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.
2 min read
Oscar Health boosts 2026 earnings outlook, affirms revenue
Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.
2 min readA Look at Oscar Health Inc (OSCR) After 4.0% Decline -- GF Value
Oscar Health Inc (OSCR) shares fell 4.0% to $32.44 on September 15, 2026. The stock's GF Value™ is $24.21, suggesting it is 34.0% overvalued. Insider activity shows net selling of $144.6M over the last 12 months. The company has a GF Score™ of 83/100, with strong growth and momentum but lower profitability.
2 min readCVS Still Sees 'High-Trend' Cost Growth; Oscar Slides
CVS Health reported ongoing high medical cost growth at a Wells Fargo conference, impacting healthcare stocks. CVS shares were stable, while UnitedHealth and Oscar Health declined.
2 min readBlackley Richard Scott sold $908K of OSCR
Blackley Richard Scott (Chief Financial Officer) sold 28,869 shares of Oscar Health, Inc. (OSCR) at $31.45 ($0.91M total) on 2026-09-03 under a Rule 10b5-1 trading plan.
1 min read